Clinical trial

Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer

NCT07441330

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Breast ultrasound Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention MRI Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention TEP-TDM Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-03-31

PhaseNA

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Breast ultrasoundPROCEDURE

MRIPROCEDURE

TEP-TDMPROCEDURE

Sponsors & collaborators

GCS Ramsay Santé pour l'Enseignement et la Recherchelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07441330 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.